Price to Earnings (P/E)
since 2005
Paying user area
Try for free
Edwards Lifesciences Corp. pages available for free this week:
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Return on Assets (ROA) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Edwards Lifesciences Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Edwards Lifesciences Corp., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 14, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2010 | = | ÷ | = | ÷ | |||||||
| Mar 2, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 29, 2008 | = | ÷ | = | ÷ | |||||||
| Mar 1, 2007 | = | ÷ | = | ÷ | |||||||
| Mar 9, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Edwards Lifesciences Corp. Annual Report.
- Share Price
-
The share price exhibited an overall upward trend during the period under review, rising from $3.48 in March 2006 to $107.73 in February 2022. Notably, there was a significant increase between 2009 and 2011, where the price rose from $4.44 to $14.17. Following a period of relative volatility and a dip in 2014 to $11.63, the price resumed strong growth, reaching above $40 by 2018 and surpassing $100 by 2022. This pattern indicates a generally positive market perception and growth in shareholder value over time.
- Earnings Per Share (EPS)
-
The EPS showed positive progression with fluctuations, beginning at $0.11 in 2006 and achieving $2.41 by 2022. The growth trajectory was not linear, with some periods indicating declines, such as a drop from $1.25 in 2014 to $0.77 in 2015. However, the company managed to regain and surpass previous EPS levels, notably increasing from 1.16 in 2019 to 2.41 in 2022. This reflects improving profitability with intermittent challenges during certain years.
- Price-to-Earnings (P/E) Ratio
-
The P/E ratio exhibited considerable volatility over the years. Initially starting at 31.2 in 2006, it decreased to the low twenties by 2008-2010, indicating a potentially undervalued or more balanced valuation relative to earnings at that time. However, from 2010 onward, the ratio rose sharply, peaking at 66.48 in 2021, before declining to 44.67 in 2022. The high P/E values in recent years suggest elevated market expectations for growth or high investor confidence despite fluctuations in earnings performance.
- Overall Insights
-
The combination of rising share prices and increasing EPS underscores sustained growth in earnings capacity and shareholder value. The variability in the P/E ratio suggests that market sentiment and growth expectations may have had a stronger influence on valuation than earnings alone. Elevated P/E levels in the later years imply optimism about future performance, though the fluctuations point to market sensitivity concerning earnings results and broader economic factors.
Comparison to Competitors
Edwards Lifesciences Corp., P/E, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | |||||||
| Feb 12, 2021 | |||||||
| Feb 14, 2020 | |||||||
| Feb 15, 2019 | |||||||
| Feb 16, 2018 | |||||||
| Feb 17, 2017 | |||||||
| Feb 19, 2016 | |||||||
| Feb 20, 2015 | |||||||
| Feb 28, 2014 | |||||||
| Feb 28, 2013 | |||||||
| Feb 27, 2012 | |||||||
| Feb 28, 2011 | |||||||
| Feb 26, 2010 | |||||||
| Mar 2, 2009 | |||||||
| Feb 29, 2008 | |||||||
| Mar 1, 2007 | |||||||
| Mar 9, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Edwards Lifesciences Corp., P/E, long-term trends, comparison to sector (health care equipment & services)
| Edwards Lifesciences Corp. | Health Care Equipment & Services | |
|---|---|---|
| Feb 14, 2022 | ||
| Feb 12, 2021 | ||
| Feb 14, 2020 | ||
| Feb 15, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 19, 2016 | ||
| Feb 20, 2015 | ||
| Feb 28, 2014 | ||
| Feb 28, 2013 | ||
| Feb 27, 2012 | ||
| Feb 28, 2011 | ||
| Feb 26, 2010 | ||
| Mar 2, 2009 | ||
| Feb 29, 2008 | ||
| Mar 1, 2007 | ||
| Mar 9, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Edwards Lifesciences Corp., P/E, long-term trends, comparison to industry (health care)
| Edwards Lifesciences Corp. | Health Care | |
|---|---|---|
| Feb 14, 2022 | ||
| Feb 12, 2021 | ||
| Feb 14, 2020 | ||
| Feb 15, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 19, 2016 | ||
| Feb 20, 2015 | ||
| Feb 28, 2014 | ||
| Feb 28, 2013 | ||
| Feb 27, 2012 | ||
| Feb 28, 2011 | ||
| Feb 26, 2010 | ||
| Mar 2, 2009 | ||
| Feb 29, 2008 | ||
| Mar 1, 2007 | ||
| Mar 9, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).